Dimensional Fund Advisors
AMLX icon

Dimensional Fund Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History

Dimensional Fund Advisors’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.5M Buy
903,192
+131,944
+17% +$1.86M ﹤0.01% 2171
2025
Q4 		$9.32M Buy
771,248
+261,468
+51% +$3.55M ﹤0.01% 2305
2025
Q3 		$6.94M Buy
509,780
+136,041
+36% +$1.28M ﹤0.01% 2433
2025
Q2 		$2.4M Buy
373,739
+250,163
+202% +$1.22M ﹤0.01% 2719
2025
Q1 		$438K Buy
123,576
+69,462
+128% +$247K ﹤0.01% 3021
2024
Q4 		$205K Buy
+54,114
New +$255K ﹤0.01% 3163

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors's AMLX Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Amylyx Pharmaceuticals (AMLX) stake by 17% in Q1 2026, buying an estimated $1.86M and bringing the position to 903,192 shares worth $12.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2171.

Dimensional Fund Advisors first reported a position in AMLX in Q4 2024 and has held it in 6 quarters since. 171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

  • Dimensional Fund Advisors held 903,192 shares of Amylyx Pharmaceuticals worth $12.5M as of Q1 2026.
  • Dimensional Fund Advisors bought 131,944 Amylyx Pharmaceuticals shares in Q1 2026, an estimated $1.86M.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2171 holding.
  • Dimensional Fund Advisors first reported a position in Amylyx Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.